Professor Patrick Kennedy

Professor Patrick Kennedy

Gastroenterology, General (internal) medicine 04500195


  • Fee assured
  • Not in Open Referral network
  • Accredited endoscopist
Fee assured
Not in Open Referral network
Accredited endoscopist

Bupa specialist

  • Accredited endoscopist


  • Face-to-face consultations
  • Video and telephone consultations

About me

Professor Kennedy is a leading liver specialist and his work in viral liver disease is known internationally. Trained in University College Dublin, he completed post-graduate training in London and was appointed as a Senior Lecturer at Barts and The London School of Medicine and Dentistry in 2009. He has produced novel work redefining disease phase in Chronic Hepatitis B (CHB) and the main focus of his research work is around broadening treatment candidacy and the development of individualized treatment strategies for viral liver disease. He is widely published in the field; over 200 publications and >90 peer reviewed articles, in addition to multiple book chapters, he has also edited a textbook of Hepatogastroenterology.

Professor Kennedy is a Consultant Physician and Hepatologist with a special interest in the management of liver disease in young people. He works closely with premiership football clubs and manages liver disease in professional sports people and elite athletes from the UK and abroad. He is an expert advisor for the WHO and is part of the HBV clinical guideline development group, he is also a member of the European association for the study of the liver (EASL) HBV clinical practice guidelines and has served as a member for NICE on the viral hepatitis clinical guideline committee. He provides expert opinion for the United Kingdom Advisory Panel (UKAP) on blood-borne viruses and is the current chair of the British Viral Hepatitis Group and former Lead for the British Association for the Study of the Liver (BASL) HBV special interest group. He works closely with industry and provides expert opinion on drug development programs.

He is the Chief/Principal Investigator for a number of investigator-led and commercial phase 1, 2 and 3, clinical trials of novel therapies in viral liver disease. At present, he leads studies on the development of novel therapies in HBV and hepatitis delta virus (HDV). In addition, he is passionate about patient education and ensuring patients play a central role in their own management. Professor Kennedy has developed HBV&Me, a management app, and a current area of his research is expanding the utility of patient management tools to improve care.

Areas of interest

Hepatology; Liver disease; Endoscopy - lower GI; Abdominal pain

Medical secretaries

Anaesthetists worked with

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • 20365

    Follow-up out-patient consultation - remote - (5-50)

  • G6500

    Diagnostic oesophago-gastro-duodenoscopy (OGD) includes forceps biopsy, biopsy urease test and dye spray - (5-50)

    London Clinic (5-50) Hospital of St John & St Elizabeth (1-5)

  • X3510

    IV sedation administered by operator - (5-50)

    London Clinic (5-50)

  • H2002

    Diagnostic colonoscopy, includes forceps biopsy of colon and ileum - (1-5)

    London Clinic (1-5)

  • H2502

    Diagnostic flexible sigmoidoscopy (including forceps biopsy and proctoscopy) - (1-5)

    Hospital of St John & St Elizabeth (1-5) London Clinic (1-5)

  • Show All (6 )...
Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.